Market Overview
The global melatonin market size was valued at USD 1.85 billion in 2024. The market is projected to grow from USD 2.08 billion in 2025 to USD 6.63 billion by 2031, exhibiting a Compound Annual Growth Rate (CAGR) of 20.5% during the forecast period.
USD 1.85 billion in 2024
2032 USD 6.63 billion by 2031
of 20.5%
Pharmaceutical Grade Melatonin
Food Grade Melatonin
Pharmaceutical Grade Melatonin dominates the market due to its stringent quality controls and high purity standards, making it the preferred choice for medical applications and therapeutic uses where consistency and safety are paramount. The demand is strongly linked to its use in prescribed sleep aids and its integration into clinical treatments for circadian rhythm disorders, driven by increasing healthcare professional recommendations. Food grade melatonin, while significant, caters primarily to the broader consumer wellness segment with less rigorous production requirements.
By Application
Dietary Supplements
Medical Others
Dietary Supplements represent the most significant application area, fueled by a global surge in consumer focus on sleep health, stress management, and overall wellness. The over-thecounter availability of melatonin in various forms like gummies, tablets, and liquids makes it highly accessible to the general population seeking natural sleep aids. The medical application, while crucial, is more regulated and targeted, primarily addressing specific sleep disorders under medical supervision. The 'Others' category includes emerging uses in functional foods and beverages, showing potential for future diversification beyond traditional supplement formats.
Our Key Players
Natrol
Pharmavite
Nature's Bounty
Jameison
Rexall Sundown
GNC
Xiu Zheng
https://www.24lifesciences.com
